Related Experiment Video
Updated: Jun 17, 2026

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels
Published on: December 13, 2024
[Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy
1Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University, Japan.
Insights
Strict blood pressure control is crucial for cardiovascular health, often requiring combination antihypertensive therapy. Calcium channel blockers offer effective blood pressure reduction with minimal side effects, making them valuable in managing hypertension.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Epidemiological studies show a linear relationship between blood pressure and cardiovascular risk, even in the normal range.
- Hypertension management often necessitates combination therapy due to the need for strict blood pressure control.
- Achieving augmented antihypertensive effects while minimizing adverse effects is key in drug combinations.
Purpose:
- To highlight the importance of strict blood pressure control in antihypertensive therapy.
- To discuss the role of combination drug therapy for hypertension.
- To emphasize the benefits of calcium channel blockers as antihypertensive agents.
Summary:
- Calcium channel blockers provide consistent, dose-dependent hypotensive effects with a low incidence of hazardous side effects.
- These agents are particularly useful in patients with co-existing angina pectoris or cerebrovascular disease.
- Their efficacy makes them beneficial in combination therapy for diabetes mellitus and chronic renal diseases requiring stringent blood pressure management.
Impact:
- Calcium channel blockers are a preferred choice for combination antihypertensive therapy.
- Their use can lead to improved cardiovascular outcomes in hypertensive patients.
- They offer a safe and effective option for managing complex cases of hypertension.
Abstract:
Because epidemiological studies have indicated that the relation of blood pressure to cardiovascular risk is lineally extended to the normal blood pressure range, strict blood pressure control is desired in the antihypertensive therapy. For this purpose, combination of multiple antihypertensive drug is required in a large part of hypertensive patients. In combining antihypertensive drugs, it is preferable that the antihypertensive effects are augmented and the adverse effects are cancelled each other. Calcium channel blockers exert consistent hypotensive effects dose-dependently and scarcely cause hazardous side effects. Calcium channel blockers are preferentially used when angina pectoris and cerebrovascular disease exist, moreover, the prominent antihypertensive effects are useful as combination drugs for the treatment of diabetes mellitus and chronic renal diseases where the strict blood pressure control is strongly needed.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Hypertension IV: Drug Therapy and Lifestyle Modifications